View Financial HealthMapath Capital 配当と自社株買い配当金 基準チェック /06Mapath Capital配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Oct 28Mapath Capital Corp. announced that it expects to receive CAD 1 million in fundingMapath Capital Corp. announced a non-brokered private placement of up to 20,000,000 common shares in the capital of the company at a price of CAD 0.05 per offered share for gross proceeds of up to CAD 1,000,000 on October 27, 2025. There are no finders' fees in connection with the offering. All securities to be issued pursuant to the offering and shares for debt will be subject to a regulatory hold period of four months and a day in accordance with the rules and policies of the TSX Venture Exchange, applicable Canadian securities laws, and such other further restrictions as may apply. Upon TSX-V acceptance, the company will close the offering. Two insiders of the company expect to purchase an aggregate of 800,000 offered shares in the offering and will receive the 568,000 common shares pursuant to the shares for debt.お知らせ • Oct 15Mapath Capital Corp., Annual General Meeting, Dec 11, 2024Mapath Capital Corp., Annual General Meeting, Dec 11, 2024.お知らせ • Sep 27Mapath Capital Corp., Annual General Meeting, Nov 16, 2023Mapath Capital Corp., Annual General Meeting, Nov 16, 2023.お知らせ • Sep 12Mapath Capital Corp. announced that it has received CAD 0.1 million in fundingOn September 11, 2023, Mapath Capital Corp. closed the transaction. The debentures and any units acquired on conversion thereof are subject to a hold period expiring on Jan. 9, 2024. No finders fees were paid in connection with the financing. Insiders of the company were issued debentures with a principal amount in aggregate of CAD 100,000. Pursuant to the financing, ROI Capital Inc., acquired a debenture of the company in the aggregate principal amount of CAD 68,000 which is convertible into 1.36 million common shares and 1.36 million warrants if converted in the first year of its term, or 680,000 common shares if converted in the second year of its term. In addition to the debenture, New, directly and indirectly, owns and/or controls, in aggregate 12,854,000 common shares, representing 49.20 per cent of the current issued and outstanding common shares. Following the completion of the financing and assuming conversion of the debenture during the first year of its term, New would own and/or control, directly and indirectly, or have control or direction over, an aggregate of 15,574,000 shares of the company, representing 51.70 per cent of the issued and outstanding common shares of the company on a diluted basis. Following the completion of the financing and assuming conversion of the debenture during the second year of its term, New would own and/or control, directly and indirectly, or have control or direction over, an aggregate of 13,534,000 shares of the company, representing 49.90 per cent of the issued and outstanding common shares of the company on a diluted basis.お知らせ • Jul 26Mapath Capital Corp. announced that it expects to receive CAD 0.1 million in fundingMapath Capital Corp. announced a non-brokered private placement to issue 10% Convertible notes for the gross proceeds of CAD 100,000 on July 25, 2023. The Notes will bear interest at the rate of 10% per annum with a 24-month term and are convertible during the Term at the option of the holder to acquire units at a price of CAD 0.04 per Unit for a period of one year from the issuance of the Notes and one common share of the Company at a price of CAD 0.04 per share for a period of one year thereafter, all subject to Exchange approval. Upon conversion in the first year, each Unit will consist of one common share of the Company and one common share purchase warrant. Each Warrant will entitle the holder to acquire one additional common share of the Company at a price of CAD 0.05 per common share for a period of one year from the issuance of the Notes. The transaction will include participation from an insider. All securities issued in connection with the Offering will be subject to a statutory and Exchange hold period of four months and a day commencing from the date of issuance. The closing of the Offering is subject to regulatory approval, including Exchange acceptance.決済の安定と成長配当データの取得安定した配当: IVFZ.Fの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: IVFZ.Fの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Mapath Capital 配当利回り対市場IVFZ.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (IVFZ.F)n/a市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Professional Services)2.6%アナリスト予想 (IVFZ.F) (最長3年)n/a注目すべき配当: IVFZ.Fは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: IVFZ.Fは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: IVFZ.Fの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: IVFZ.Fが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/03/28 18:13終値2025/12/29 00:00収益2025/09/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Mapath Capital Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Siddharth RajeevFundamental Research Corp.
お知らせ • Oct 28Mapath Capital Corp. announced that it expects to receive CAD 1 million in fundingMapath Capital Corp. announced a non-brokered private placement of up to 20,000,000 common shares in the capital of the company at a price of CAD 0.05 per offered share for gross proceeds of up to CAD 1,000,000 on October 27, 2025. There are no finders' fees in connection with the offering. All securities to be issued pursuant to the offering and shares for debt will be subject to a regulatory hold period of four months and a day in accordance with the rules and policies of the TSX Venture Exchange, applicable Canadian securities laws, and such other further restrictions as may apply. Upon TSX-V acceptance, the company will close the offering. Two insiders of the company expect to purchase an aggregate of 800,000 offered shares in the offering and will receive the 568,000 common shares pursuant to the shares for debt.
お知らせ • Oct 15Mapath Capital Corp., Annual General Meeting, Dec 11, 2024Mapath Capital Corp., Annual General Meeting, Dec 11, 2024.
お知らせ • Sep 27Mapath Capital Corp., Annual General Meeting, Nov 16, 2023Mapath Capital Corp., Annual General Meeting, Nov 16, 2023.
お知らせ • Sep 12Mapath Capital Corp. announced that it has received CAD 0.1 million in fundingOn September 11, 2023, Mapath Capital Corp. closed the transaction. The debentures and any units acquired on conversion thereof are subject to a hold period expiring on Jan. 9, 2024. No finders fees were paid in connection with the financing. Insiders of the company were issued debentures with a principal amount in aggregate of CAD 100,000. Pursuant to the financing, ROI Capital Inc., acquired a debenture of the company in the aggregate principal amount of CAD 68,000 which is convertible into 1.36 million common shares and 1.36 million warrants if converted in the first year of its term, or 680,000 common shares if converted in the second year of its term. In addition to the debenture, New, directly and indirectly, owns and/or controls, in aggregate 12,854,000 common shares, representing 49.20 per cent of the current issued and outstanding common shares. Following the completion of the financing and assuming conversion of the debenture during the first year of its term, New would own and/or control, directly and indirectly, or have control or direction over, an aggregate of 15,574,000 shares of the company, representing 51.70 per cent of the issued and outstanding common shares of the company on a diluted basis. Following the completion of the financing and assuming conversion of the debenture during the second year of its term, New would own and/or control, directly and indirectly, or have control or direction over, an aggregate of 13,534,000 shares of the company, representing 49.90 per cent of the issued and outstanding common shares of the company on a diluted basis.
お知らせ • Jul 26Mapath Capital Corp. announced that it expects to receive CAD 0.1 million in fundingMapath Capital Corp. announced a non-brokered private placement to issue 10% Convertible notes for the gross proceeds of CAD 100,000 on July 25, 2023. The Notes will bear interest at the rate of 10% per annum with a 24-month term and are convertible during the Term at the option of the holder to acquire units at a price of CAD 0.04 per Unit for a period of one year from the issuance of the Notes and one common share of the Company at a price of CAD 0.04 per share for a period of one year thereafter, all subject to Exchange approval. Upon conversion in the first year, each Unit will consist of one common share of the Company and one common share purchase warrant. Each Warrant will entitle the holder to acquire one additional common share of the Company at a price of CAD 0.05 per common share for a period of one year from the issuance of the Notes. The transaction will include participation from an insider. All securities issued in connection with the Offering will be subject to a statutory and Exchange hold period of four months and a day commencing from the date of issuance. The closing of the Offering is subject to regulatory approval, including Exchange acceptance.